Story Poster
Clemson Baseball

Fourth Inning Propels No. 9 Cavaliers Over Clemson 11-6

May 14, 2022
1,665

CHARLOTTESVILLE, VA. - No. 9 Virginia scored seven runs in the fourth inning and four runs in the eighth inning in its 11-6 victory over Clemson in the series opener at Disharoon Park in a game that started on Friday and ended on Saturday.

The Tigers (31-19, 9-15 ACC) plated three runs in the first inning, including one on Blake Wright’s two-out, run-scoring single that extended his hitting streak to 10 games and RBI streak to 12 games. Two batters later, Tyler Corbitt belted a two-run homer, his 11th of the year. Jonathan French led off the second inning with a home run, his eighth of the year.

The Cavaliers (36-12, 15-10 ACC) dented the scoreboard with one out in the fourth inning on Ethan Anderson’s two-run triple as rain began to fall. Four batters later with two outs, Kyle Feel drew a walk, the fourth of the inning, with the bases loaded, then Max Cotier tied the score 4-4 on a wild pitch. Seconds later, play was suspended due to inclement weather and delayed until the following day. The Cavaliers added three more runs, highlighted by Devin Ortiz’s two-run single to cap their seven-run frame, which included five two-out runs.

In the fifth inning, Max Wagner crushed a two-run homer, his 24th of the season, to narrow Virginia’s lead to 7-6. The Cavaliers added four insurance runs in the eighth inning.

Matthew Buchanan (3-1) retired all three batters he faced in relief to earn the win, while Brandon Neeck pitched 1.2 innings to record his third save of the year. Tiger starter Mack Anglin (5-5) suffered the loss.

The series continues Saturday at approximately 3:30 p.m. on ACC Network Extra.

Discussion from...

Fourth Inning Propels No. 9 Cavaliers Over Clemson 11-6

1,660 Views | 0 Replies | Last: 2 yr ago by CU Athletic Communications
There are not any replies to this post yet.
Refresh
Page 1 of 1
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.